Comparative Pharmacology
Head-to-head clinical analysis: MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE versus QDOLO.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE versus QDOLO.
MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE vs QDOLO
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Meperidine is a synthetic opioid agonist that exerts its analgesic effects by binding to mu-opioid receptors in the central nervous system, thereby mimicking the actions of endogenous opioids. It also has some kappa-opioid receptor activity and weak serotonergic effects.
Tramadol is a centrally acting synthetic opioid analgesic. It binds to μ-opioid receptors and inhibits norepinephrine and serotonin reuptake.
50-100 mg IM/SC every 3-4 hours as needed; 25-50 mg IV slowly every 3-4 hours as needed.
Oral: 50-100 mg every 4-6 hours as needed for pain; maximum 400 mg per day. Immediate-release tablets only. Extended-release formulations require different dosing and are not interchangeable.
None Documented
None Documented
Terminal elimination half-life: 2.5–4 hours (mean 3.2 h). In cirrhosis, half-life prolonged to 7–11 hours; in elderly, half-life extends up to 8 hours. Normeperidine (active metabolite) half-life: 15–30 hours (accumulates with renal impairment).
Terminal elimination half-life approximately 2-4 hours in adults; prolonged to 4-6 hours in elderly and up to 12-16 hours in severe renal impairment (CrCl <30 mL/min)
Primarily renal (90% as metabolites, ~5-30% unchanged); biliary/fecal excretion accounts for <10%. Urinary excretion is pH-dependent; acidic urine increases elimination.
Renal 90% (60% unchanged, 30% as glucuronide conjugate), fecal 10%
Category D/X
Category C
Opioid Agonist
Opioid Agonist